Press Release

In-Vitro Toxicology Testing Market 2019 Significant Growth Rate by Industry Size, Share, Market Dynamics, Development Status of Key Players Forecast to 2024

In-Vitro

The “In-Vitro Toxicology Testing Market” research report 2019-2024 delivers comprehensive information and valuable insights about the In-Vitro Toxicology Testing industry. The information available in the In-Vitro Toxicology Testing market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. In-Vitro Toxicology Testing market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the In-Vitro Toxicology Testing Market:

  • Abbott Laboratories
  • Agilent Technologies
  • Bio
  • Rad Laboratories
  • Covance
  • Eurofins Scientific
  • GE Healthcare
  • Merck KGaA
  • Promega Corporation
  • Quest Diagnostics
  • Thermo Fisher Scientific

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099024

    Market Overview:

  • The in-vitro toxicology testing market is expected to witness a CAGR of 7.1% during the forecast period. Factors that are driving market growth include the opposition to the use of animals in pre-clinical research, significant advancements in-vitro toxicology assays, and growing awareness regarding drug product safety.
  • In-vitro tests provide toxicity information in a cost-effective and timesaving manner. It is anticipated that rapid advances in biomedical sciences will result in the development of newer and advanced in-vitro test strategies for hazard characterization. Toxicity testing is slowly becoming proficient with various advanced technologies aiding the process. It is currently poised to take advantage of promising revolutions from the field of biotechnology. The applications of toxicity testing are set to increase with advances in biotechnology, resulting in a demand for the same in the market. The advances in toxicity testing practices, such as bioinformatics, computational toxicology, epigenetics, etc., hold the potential for a paradigm shift from whole-animal testing to in-vitro methods that evaluate changes in various processes, which use cell lines and other cellular components. A number of emerging fields and techniques are contributing major new insights for understanding biologic responses to chemicals in human tissues. These advances are expected to drive the growth of the in-vitro toxicology market during the forecast period.
  • However, the screening process is quite stringent for the approval of any healthcare molecule. Many molecules fail in the toxicity study stage and are barred from entering the market. In-vitro toxicology testing as an alternative to animal testing is by default always under the lens, as it is intended to replace a fully approved method for toxicity study (animal testing). This is because in-vitro toxicology testing has to match closely to the standards from in-vivo animal testing. Regulators, including the United States Food and Drug Administration (FDA), has issued guidance with regard to in-vitro studies to be conducted during drug development. However, current regulatory guidance does not address specific study designs for in-vitro toxicity testing. The experimental procedures and documentation of data for in-vitro testing should be rigorous, reproducible, with specific analytical methods, along with documentation of assay procedures and results. Therefore, these stringent regulations are restraining the growth of the in-vitro toxicology testing market, globally. Other factors, such as incapability of in-vitro models to determine autoimmunity and immunostimulation, are also acting as major restraints for the market studied.

    Scope of the Report:

  • In-vitro toxicity testing is referred to as the method of scientifically analyzing the effects of lethal or toxic chemical materials either on mammalian cells or on cultured bacteria. In-vitro testing methods are performed mainly for the purpose of identifying potentially harmful chemicals and/or for confirming the deficiency of certain toxic properties in the initial stages of the development of possibly useful novel substances, including therapeutic drugs, agricultural chemicals, and even food additives.

    Reasons for Buying In-Vitro Toxicology Testing Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099024

    Key Market Trends:

    Cell Culture is Expected to Hold Significant Market Share in the Technology Type

    Recent inventions and advances in human cell culture exposure, as well as test systems, have allowed the expansion and development of in-vitro assay systems, which are predictive, demonstrative and suitable for toxicity screening of a varied range of chemicals including nanomaterials and airborne materials. In-vitro toxicology involves using cells or tissues grown or maintained in a controlled laboratory environment to examine the toxic properties of various compounds and mixtures. This further enables one to examine the toxicity of xenobiotics at the basic level of the cell without involving the interplay of complex physiological systemic effects, which are often observed in entire organisms. However, definite cellular functions could be studied with primary cell cultures obtained from specific tissues such as the kidney or gills for ionic homeostasis, liver for xenobiotic biotransformation, and the nerve cells for neurotransmitter signaling effects.

    North America Dominates the Market and is Expected to Do So in the Forecast Period

    Over the past few years, technical advancements and supportive government regulations have led to the rapid development of innovative, cost-effective testing for establishing drug, device, chemical and cosmetic safety, in North America. The significant increase in investment in instruments and the ongoing expansion of laboratory capabilities, across the region, currently, enable clients to establish toxicological profiles of medical devices, biopharmaceuticals, cosmetics, and chemicals. These investments include an expansion of the existing cell/tissue culture capabilities, flow cytometry, and mass spectrometry facilities, apart from the introduction of high throughput screening, automation, and multiplexing technologies for biomarker analysis.

    In-Vitro Toxicology Testing Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14099024

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of In-Vitro Toxicology Testing Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Opposition to the Usage of Animals in Pre-clinical Research
    4.2.2 Significant Advancements In-vitro Toxicology Assays
    4.2.3 Increasing Awareness Regarding Drug Product Safety
    4.3 Market Restraints
    4.3.1 Incapability of In-vitro Models to Determine Autoimmunity and Immunostimulation
    4.3.2 Stringent Regulatory Framework for the In-vitro Tests
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Technology
    5.1.1 Cell Culture
    5.1.2 High Throughput
    5.1.3 Molecular Imaging
    5.1.4 OMICS
    5.2 By Method
    5.2.1 Cellular Assay
    5.2.2 Biochemical Assay
    5.2.3 In Silica
    5.2.4 Ex-vivo
    5.3 By Application
    5.3.1 Systemic Toxicology
    5.3.2 Dermal Toxicity
    5.3.3 Endorine Disruption
    5.3.4 Occular Toxicity
    5.3.5 Other Applications
    5.4 By End User
    5.4.1 Pharmaceutical Industry
    5.4.2 Cosmetics & Household Products
    5.4.3 Diagnostics
    5.4.4 Chemicals Industry
    5.4.5 Food Industry
    5.5 Geography
    5.5.1 North America
    5.5.1.1 US
    5.5.1.2 Canada
    5.5.1.3 Mexico
    5.5.2 Europe
    5.5.2.1 Germany
    5.5.2.2 UK
    5.5.2.3 France
    5.5.2.4 Italy
    5.5.2.5 Spain
    5.5.2.6 Rest of Europe
    5.5.3 Asia-Pacific
    5.5.3.1 China
    5.5.3.2 Japan
    5.5.3.3 India
    5.5.3.4 Australia
    5.5.3.5 South Korea
    5.5.3.6 Rest of Asia-Pacific
    5.5.4 Middle East & Africa
    5.5.4.1 GCC
    5.5.4.2 South Africa
    5.5.4.3 Rest of Middle East & Africa
    5.5.5 South America
    5.5.5.1 Brazil
    5.5.5.2 Argentina
    5.5.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abbott Laboratories
    6.1.2 Agilent Technologies
    6.1.3 Bio-Rad Laboratories
    6.1.4 Covance
    6.1.5 Eurofins Scientific
    6.1.6 GE Healthcare
    6.1.7 Merck KGaA
    6.1.8 Promega Corporation
    6.1.9 Quest Diagnostics
    6.1.10 Thermo Fisher Scientific

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Sevoflurane (Sevoflurane Source) Market Share, Size 2019 Growing Rapidly with Modern Trends, Development, Revenue, Demand and Forecast to 2024 | Says Industry Research Biz

    Hydroelectric Generator Market 2019 – Business Revenue, Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Share, Global Size Analysis by Forecast to 2024 | Industry Research Biz

    Cardiac Monitoring Market 2019-2023 | Global Competitive Landscape on Size, Volume, Trends, Share and Revenue With Leading Players Overview, Regional Forecast

    Global Barrier Materials Market Analysis and Forecast to 2025 by Recent Trends, Developments in Manufacturing Technology and Regional Growth Overview

    Tags
  • Alfredoo Epps

    Alfredo Epps is a finance expert heading the petroleum column. He joined the group last year as an associate writer. But his thorough research skills and ability to seamlessly putting numerical data into words helped him get a senior position. Apart from a column head, Alfredo is a dancer and a violinist.

    Related Articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Close